Cme Group Inc. CME
We take great care to ensure that the data presented and summarized in this overview for CME GROUP INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CME
View all-
Vanguard Group Inc Valley Forge, PA33.9MShares$8.07 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY25.7MShares$6.11 Billion0.12% of portfolio
-
State Street Corp Boston, MA15.9MShares$3.78 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA12.1MShares$2.89 Billion0.43% of portfolio
-
Morgan Stanley New York, NY11.1MShares$2.64 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY10.5MShares$2.49 Billion0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA8.28MShares$1.97 Billion0.15% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN4.79MShares$1.14 Billion0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.36MShares$1.04 Billion0.11% of portfolio
-
Invesco Ltd. Atlanta, GA4.21MShares$1 Billion0.19% of portfolio
Latest Institutional Activity in CME
Top Purchases
Top Sells
About CME
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Insider Transactions at CME
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2024
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
750
-3.95%
|
$169,500
$226.33 P/Share
|
|
Nov 04
2024
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
400
-1.57%
|
$88,800
$222.92 P/Share
|
|
Oct 30
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,500
-14.26%
|
$1,017,000
$226.64 P/Share
|
|
Oct 30
2024
|
Timothy S. Bitsberger Director |
SELL
Open market or private sale
|
Direct |
1,000
-4.41%
|
$226,000
$226.96 P/Share
|
|
Oct 28
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Open market or private sale
|
Direct |
1,374
-15.89%
|
$311,898
$227.12 P/Share
|
|
Sep 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
12
+0.51%
|
$2,616
$218.5 P/Share
|
|
Sep 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
280
+0.11%
|
$61,040
$218.5 P/Share
|
|
Sep 16
2024
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,456
+22.44%
|
$5,985,408
$218.53 P/Share
|
|
Sep 16
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+8.18%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+23.41%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+9.72%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
852
+3.49%
|
$185,736
$218.53 P/Share
|
|
Sep 16
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+26.31%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
2,744
+30.28%
|
$598,192
$218.53 P/Share
|
|
Sep 16
2024
|
Jonathan L Marcus Sr MD General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,744
+27.14%
|
$598,192
$218.53 P/Share
|
|
Sep 16
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+9.05%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+17.61%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+10.25%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+12.42%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+24.46%
|
$673,184
$218.53 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 169K shares |
|---|---|
| Bona fide gift | 3.79K shares |
| Open market or private sale | 556 shares |
| Open market or private purchase | 2.58K shares |
| Payment of exercise price or tax liability | 62.7K shares |
|---|---|
| Open market or private sale | 70.7K shares |
| Bona fide gift | 4.33K shares |